Eyepoint Pharma

$11.09 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Eyepoint Pharma

EyePoint Pharmaceuticals, Inc. operates as a biopharmaceutical company. The Company specializes in the development of drug devices to treat debilitating diseases of the eye disorders and other chronic conditions. EyePoint Pharmaceuticals serves customers worldwide.

Stock Analysis

last close $11.09
1-mo return 34.9%
3-mo return 27.6%
avg daily vol. 192.02T
52-week high 21.5
52-week low 7
market cap. $359M
forward pe -
annual div. -
roe -59.3%
ltg forecast -
dividend yield -
annual rev. $41M
inst own. 89.8%
baraka

Subscribe now for daily local and international financial news

Subscribe